| Financial Year |
March 31 2023 |
| Monetary Funds |
1,404,358,461.47 |
| Held-for-trading Financial Assets |
1,290,564,736.61 |
| Notes Receivable |
30,000.00 |
| Accounts Receivable |
39,451,171.80 |
| Advances to Suppliers |
36,476,207.64 |
| Other Receivables |
15,299,305.56 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
169,699,698.92 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
34,463,812.95 |
| Total Current Assets |
3,009,020,619.13 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
310,071,388.08 |
| Investment Properties |
-- |
| Fixed Assetes |
19,113,362.35 |
| Under-construction Projects |
558,142.30 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
554,550.93 |
| R&D expenses |
-- |
| Goodwill |
17,386,934.67 |
| Long-Term Deferred and Prepaid Expenses |
15,632,491.68 |
| Deferred Income Tax Assets |
187,432,293.99 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
2,643,613,353.68 |
| Total Assets |
5,652,633,972.81 |
| Short-Term Loans |
500,306,944.42 |
| Trading Financial liabilities |
3,000,000.00 |
| Notes Payable |
-- |
| Accounts Payable |
203,038,800.60 |
| Accounts Received In Advance |
213,448,239.55 |
| Employee Compensation Payable |
44,632,496.82 |
| Taxes Payable |
12,391,201.54 |
| Interest Payable |
-- |
| Dividend Payable |
61,830,548.95 |
| Other payables |
349,757,396.61 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
87,432,701.58 |
| Other Current Liabilities |
4,791,080.31 |
| Sub-Total of Current Liabilities |
1,547,164,173.21 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
104,774,493.65 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
495,803,148.11 |
| Total Liabilities |
2,042,967,321.32 |
| Paid-In Capital(Or Share Stock) |
532,761,055.00 |
| Capital Surplus |
28,638,031.60 |
| Surplus Reserve |
258,442,366.75 |
| LESS:Treasury Stock |
4,137,097.00 |
| Undistributed Profits |
2,757,936,757.46 |
| Minority Stockholder's Interest |
61,619,954.26 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,548,046,697.23 |
| Owner's Equity（Stockholder's Equity） |
3,609,666,651.49 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,652,633,972.81 |
